AD/PD
2024 International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders in Lisbon, Portugal (March 5-9, 2024)

• Zhao J, Gu M, Yu M, Barros De Paula R, Bellen H, Shulman J. Dissecting oligogenic mechanisms of lysosomal susceptibility in Parkinson's disease. Presented at the AD/PD, 2024 International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders in Lisbon, Portugal (March 5-9, 2024).  

American Academy of Neurology (AAN)
75^th Annual Meeting in Boston, Mass. (April 22-28, 2023)

• Shulman J, Vanegas-Arroyave N, Fong J, Elsea S, Lin C, Saade H, et al. Precision neurology for dementia. Presented at the American Academy of Neurology (AAN), 75^th Annual Meeting in Boston, Mass. (April 22-28, 2023).  

2022 Alzheimer's Association International Conference (AAIC)
San Diego, Calif. (July 30 - Aug. 4, 2022)

• Fong JC, Chavez F, Silos K, Castro GC, Arroyo-Miranda ML, Kunik ME, et al. "Hablemos de Alzheimer": Words Mexican Americans use to talk about Alzheimer's disease genetic testing. Implications for precision medicine education. Presented at the 2022 Alzheimer's Association International Conference (AAIC), San Diego, Calif. (July 30 - Aug. 4, 2022).  
• Li-Kroeger D, Al-Ramahi I, Marella A, Amoh BK, Smith N, Botas J, et al. A matrisomal proteomics network modulates tau and amyloid-beta toxicity in fly AD models. Presented at the 2022 Alzheimer's Association International Conference (AAIC), San Diego, Calif. (July 30 - Aug. 4, 2022).  
• Wu T, Guo C, Deger JM, Dhindsa J, Al-Ouran R, Shulman JM. Cell-specific responses to Tau pathology in the aging brain. Presented at the 2022 Alzheimer's Association International Conference (AAIC), San Diego, Calif. (July 30 - Aug. 4, 2022).  
• Ye H, Bagchi P, Wu T; Dammer EB, Seyfried NT, Shulman JM. Retromer subunit, VPS29, regulates vacuolar-type ATPase and lysosomal acidification in the aging brain. Presented at the 2022 Alzheimer's Association International Conference (AAIC), San Diego, Calif. (July 30 - Aug. 4, 2022).  

Society for Neuroscience (SFN)
Virtual Annual Meeting (Nov. 8-11, 2021)

• Lee TV, Allison K, Seyfried NT, Levey AI, Shulman JM. Functional validation of the cytoskeletal protein Plectin in Alzheimer's disease. Program No. 224.07. 2021 Neuroscience Meeting Planner. Society for Neuroscience, 2021. Online. 
• Paveskovic M, Ojelade S, Pekarek B, Kochukov M, Arenkiel B, Shulman J. Alzheimer's disease risk gene CD2AP modulates synaptic structure and plasticity. Program No. 212.11. 2021 Neuroscience Meeting Planner. Society for Neuroscience, 2021. Online. 

2021 Alzheimer's Association International Conference (AAIC)
Virtual Meeting (July 26-30, 2021)

• Cary GA, Gockley J, Lehallier B, Leal K, Greenwood AK, Shulman JM, et al. Integrating multimodal data to support Alzheimer's disease target prioritization. Presented at the 2021 Alzheimer's Association International Conference (AAIC), Virtual Meeting (July 26-30, 2021).  
• Paveskovic M, Ojelade SA, Kochukov M, Pekarek B, Arenkiel B, Shulman JM. The Alzheimer's disease risk gene CD2AP modulates mammalian synaptic structure and plasticity. Presented at the 2021 Alzheimer's Association International Conference (AAIC), Virtual Meeting (July 26-30, 2021).  
• Wu T, Guo C, Shulman JM. Elucidiating cellular contributions to tau-mediated neurodegeneration using Drosophila and single cell transcriptomics. Presented at the 2021 Alzheimer's Association International Conference (AAIC), Virtual Meeting (July 26-30, 2021).  

2020 Alzheimer's Association International Conference (AAIC)
Virtual Meeting (July 27-31, 2020)

• Johnson ECB, Dammer EB, Duong D, Ping L, Zhou M, Yin L, et al. A consensus proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Presented at the 2020 Alzheimer's Association International Conference (AAIC), Virtual Meeting (July 27-31, 2020).  

American Academy of Neurology (AAN)
72^nd Annual Meeting in Toronto, Ontario, Canada (April 25 - May 1, 2020)

• Hill E, Deger J, Robak L, Rao S, Saade H, Ripperger B, et al. Addressing challenges of clinical comprehensive genetic testing in Parkinson's disease. Neurology. 2020;94(15 Suppl):5267. 

Society for Neuroscience (SFN)
49^th Annual Meeting in Chicago, Ill. (Oct. 19-23, 2019)

• Paveskovic M, Ojelade SA, Pekarek BT, Arenkiel BR, Shulman JM. Investigating the role of CD2AP, an Alzheimer's disease susceptibility gene, in mammalian synaptic structure and function. Program No. 559.21. 2019 Neuroscience Meeting Planner. Chicago, IL: Society for Neuroscience, 2019. Online. 

American Neurological Association (ANA)
144^th Annual Meeting in St. Louis, Mo. (Oct. 13-15, 2019)

• Johnson ECB, Dammer EB, Duong DM, Yin L, Betarbet R, Shulman JM, et al. A consensus Alzheimer's disease brain protein co-expression network identifies robust biological alterations associated with early- and late-stage disease. Ann Neurol. 2019;86(Suppl 24):S242. 
• Johnson ECB, Dammer EB, Duong DM, Yin L, Betarbet R, Shulman JM, et al. Biological alterations associated with early- and late-stage disease. Ann Neurol. 2019;86(Suppl 24):S230. 
• Robak L, Shulman J. Parkinson's disease susceptibility in carriers of lysosomal storage disorder genes. Ann Neurol. 2019;86(Suppl 24):S275. 

2019 Alzheimer's Association International Conference (AAIC)
Los Angeles, Calif. (July 14-18, 2019)

• Guo C, Hsieh Y-C, Yalamanchili HK, Abreha M, Al-Ouran R, Li Y, et al. Tau-mediated disruption of the spliceosome triggers cryptic RNA splicing and neurodegeneration in Alzheimer's disease. Presented at the 2019 Alzheimer's Association International Conference (AAIC), Los Angeles, Calif. (July 14-18, 2019).  
• Lee TV, Allison KS, Ojelade SA, Lah JJ, Levey AI, Seyfried NT, et al. Functional dissection of an Alzheimer's disease susceptibility gene network. Presented at the 2019 Alzheimer's Association International Conference (AAIC), Los Angeles, Calif. (July 14-18, 2019).  
• Mangleburg CG, Wan Y-W, Al-Ouran R, Lee TV, Allison KS, Logsdon BA, et al. Functional dissection of Alzheimer's disease brain gene expression signatures in humans and mouse models. Presented at the 2019 Alzheimer's Association International Conference (AAIC), Los Angeles, Calif. (July 14-18, 2019).  

American Academy of Neurology (AAN)
71^st Annual Meeting in Philadelphia, Penn. (May 4-10, 2019)

• Alfradique-Dunham I, Blauwendraat C, Al-Ouran R, von Coelln R, Tan M, Hill EJ, et al. Genome-wide association study meta-analysis for Parkinson disease motor subtypes. Neurology. 2019;92(15 Suppl):S53.005. [Platform Presentation] 
• Hill EJ, Alfradique-Dunham I, Mangleburg CG, Ripperger B, Stillwell A, Rao S, et al. Capturing Parkinson's disease heterogeneity with quantitative mobility measures. Neurology. 2019;92(15 Suppl):S10.006. [Platform Presentation] 

Society for Neuroscience (SFN)
48^th Annual Meeting in San Diego, Calif. (Nov. 3-7, 2018)

• Logsdon B, Perumal TM, Swarup V, Funk C, Allen M, Wang M, et al. Sex specific Alzheimer's disease heterogeneity identified through cross study integrative analysis of RNA-seq data from the AMP-AD consortium. Program No. 466.06. 2018 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2018. Online. 
• Ojelade SA, Lee TV, Giagtzoglou N, Shulman J. cindr, the Drosophila homolog of CD2AP, plays a conserved role in synapse function and protein turnover. Program No. 187.04. 2018 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2018. Online. 
• Vazquez-Velez G, Rousseaux MW, Al-Ramahi I, Jeong H-H, Bajic AS, Revelli J-P, et al. A druggable genome screen identifies modifiers of α-synuclein levels via a tiered cross-species validation approach. Program No. 470.13. 2018 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2018. Online. 

Movement Disorder Society (MDS)
22^nd International Congress of Parkinson's Disease and Movement Disorders in Hong Kong, China (Oct. 5-9, 2018)

• Robak L, Du R, Yuan B, Gu S, Akdemir Z, Jankovic J, et al. Integrated whole exome sequencing and chromosomal microarray in familial Parkinson's disease. Mov Disord. 2018;33 Suppl 2:S606. 
• von Coelln R, Dawe R, Shulman J, Yu L, Leurgans S, Hausdorff J, et al. Quantitative mobility metrics from a body-fixed sensor predict incident parkinsonism in older adults. Mov Disord. 2018;33 Suppl 2:S417. 
• Ye H, Li-Kroeger D, Li Y, Bellen H, Shulman J. Loss of VPS29 disrupts retromer function and synaptic transmission, leading to neurodegeneration in Drosophila. Mov Disord. 2018;33 Suppl 2:S632. 

2018 Alzheimer's Association International Conference (AAIC)
Chicago, Ill. (July 22-26, 2018)

• Ojelade SA, Lee TV, Giagtzoglou N, Shulman JM. Cindr, the Drosophila homolog of CD2AP, affects synapse function and protein turnover. Alzheimers Dement. 2018;14(7 Suppl):P720. 

American Academy of Neurology (AAN)
70^th Annual Meeting in Los Angeles, Calif. (April 21-27, 2018)

• Alfradique-Dunham I, Robak L, Kaw A, Fagbongbe OI, Akdemir ZC, Young E, et al. Whole exome sequencing in essential tremor. Neurology. 2018;90(15 Suppl):P6.061.  [View poster]
• Robak L, Du R, Yuan B, Gu S, Akdemir ZC, Tejomurtula A, et al. Integrated whole exome sequencing and chromosomal microarray in familial Parkinson's disease. Neurology. 2018;90(15 Suppl):N3.001. 

Society for Neuroscience (SFN)
47^th Annual Meeting in Washington, DC (Nov. 11-15, 2017)

• Daily K, Logsdon B, Peters M, Al-Ouran R, Wan YW, Shulman JM, et al. Systems biology resource for Alzheimer's disease target prioritization: The AMP-AD Knowledge Portal. Program No. 207.15. 2017 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2017. Online. 
• Hsieh Y-C, Guo C, Yalamanchili HK, Li Y, Lasagna-Reeves CA, Xu Y, et al. Tau-mediated disruption of the spliceosome in Alzheimer's disease models. Program No. 547.04. 2017 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2017. Online. 

Movement Disorder Society (MDS)
21^st International Congress of Parkinson's Disease and Movement Disorders in Vancouver, BC, Canada (June 4-8, 2017)

• Alfradique-Dunham I, Robak LA, Kaw A, Fagbongbe OI, Ternes K, Young E, et al. Whole exome sequencing in essential tremor. Mov Disord. 2017;32 Suppl 2:S294.  [View poster]

American Academy of Neurology (AAN)
69^th Annual Meeting in Boston, Mass. (April 22-28, 2017)

• Robak L, Jansen I, van Rooij J, Uitterlinden A, Kraaj R, Heutink P, et al. Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease. Neurology. 2017;88(16 Suppl):S1.001. [Platform Presentation] 
• Shulman J, Jansen I, Ye H, Heetveld S, Gibbs JR, Chouhan A, et al. Discovery and systematic functional validation of Parkinson's disease genes from exome sequencing. Neurology. 2017;88(16 Suppl):S1.003. [Platform Presentation]  [View poster]

Movement Disorder Society (MDS)
19^th International Congress of Parkinson's Disease and Movement Disorders in San Diego, Calif. (June 14-18, 2015)

• Parnes M, Robak L, Shulman JM, Stocco A, Jankovic J. Dystonia-spasticity in a patient with a novel SLC25A12 mutation. Mov Disord. 2015;30 Suppl 1:S480. 

American Academy of Neurology (AAN)
67^th Annual Meeting in Washington, DC (April 18-25, 2015)

• Parnes M, Robak L, Shulman J, Stocco A, Jankovic J. Dystonia-spasticity in a patient with a novel SLC25A12 mutation. Neurology. 2015;84(Meeting Abstracts 1):P2.138.  [View poster]

American Academy of Neurology (AAN)
65^th Annual Meeting in San Diego, Calif. (March 16-23, 2013)

• Shulman J, Yu L, Buchman A, Evans D, Schneider J, Bennett D, et al. Exploring the impact of Parkinson disease (PD) susceptibility genes in elders without PD. Neurology. 2013;80(Meeting Abstracts 1):S13.006. [Platform Presentation] 

American Neurological Association (ANA)
137^th Annual Meeting in Boston, Mass. (Oct. 7-9, 2012)

• Shulman JM, Chen K, Keenan BT, Chibnik LB, Thiyyagura P, McCabe C, et al. Genetic susceptibility for amyloid pathology in Alzheimer's disease. Ann Neurol. 2012;72 Suppl 16:S51. 
• Shulman JM, Imboywa S, Diamond AE, Chipendo P, De Jager PL, Feany MB. Integrating human and fly genetics to understand Alzheimer's disease susceptibility. Ann Neurol. 2012;72 Suppl 16:S51. 

Parkinson Study Group (PSG)
26^th Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson Disease and Other Movement Disorders in Irving, Texas (May 11, 2012)

• Shulman JM. Genetic analyses of Parkinson's disease endophenotypes. Presented at the Parkinson Study Group (PSG), 26^th Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson Disease and Other Movement Disorders in Irving, Texas (May 11, 2012). [Platform Presentation] 

American Neurological Association (ANA)
136^th Annual Meeting in San Diego, Calif. (Sept. 25-27, 2011)

• Shulman JM, Chipendo PI, Chibnik LB, Keenan BT, Tran D, Huentelman MA, et al. Integrating genome-wide association and functional validation to understand susceptibility for Alzheimer's pathology. Ann Neurol. 2011;70 Suppl 15:S50-1. [Platform Presentation] 

Michael J. Fox Parkinson's Research Foundation
Genetic Epidemiology of Parkinson's Disease Consortium Meeting in Evanston, Ill. (Sept. 18-21, 2011)

• Shulman JM. What can endophenotypes teach us about Parkinson's disease? Presented at the Michael J. Fox Parkinson's Research Foundation, Genetic Epidemiology of Parkinson's Disease Consortium Meeting in Evanston, Ill. (Sept. 18-21, 2011). [Oral Presentation] 

2011 International Conference on Alzheimer's Disease (ICAD)
Paris, France (July 16-21, 2011)

• Keenan B, Shulman J, Chibnik L, Corneveaux J, Allen A, Myers A, et al. A candidate causal variant in the CR1 locus. Alzheimers Dement. 2011;7(4 Suppl):S496-S7. 
• Raj T, Shulman J, Chibnik L, Keenan B, Stranger B, Evans D, et al. Alzheimer's disease susceptibility loci: Evidence for natural selection and altered gene expression. Alzheimers Dement. 2011;7(4 Suppl):S183. 
• Sherva R, Tripodis Y, Shulman J, Chibnik L, Crane P, Bennett D, et al. Genetic factors associated with the rate of cognitive decline in Alzheimer's disease. Alzheimers Dement. 2011;7(4 Suppl):S496. 
• Shulman J, Chibnik L, Keenan B, Destefano A, Leurgans S, Wilson R, et al. A genome-wide association scan for episodic memory decline in aging. Alzheimers Dement. 2011;7(4 Suppl):S195. 
• Shulman J, Chipendo P, Chibnik L, Keenan B, Tran D, Aubin C, et al. Integrating genome-wide association and functional validation to understand susceptibility for Alzheimer's pathology. Alzheimers Dement. 2011;7(4 Suppl):S497. [Platform Presentation] 

American Academy of Neurology (AAN)
63^rd Annual Meeting in Honolulu, Hawaii (April 9-16, 2011)

• Shulman JM, Chibnik LB, Leurgans SE, Wilson RS, Tran D, Keenan BT, et al. A genome-wide association scan for episodic memory decline in aging. Neurology. 2011;76(Suppl 4):A1-2. [Platform Presentation] 
• Shulman JM, Keenan BT, Chibnik LB, Raj T, Tran D, Aubin C, et al. Functional fine mapping of the CR1 locus identifies a causal variant for Alzheimer's disease susceptibility. Neurology. 2011;76(Suppl 4):A642. [Platform Presentation] 

Keystone Symposium
Symposium on Neurodegenerative Diseases in Taos, N.M. (Feb. 21-26, 2011)

• Shulman JM. Enhancing power for gene discovery in Alzheimer's disease: Intermediate phenotypes and functional validation in drosophila. Presented at the Keystone Symposium, Symposium on Neurodegenerative Diseases in Taos, N.M. (Feb. 21-26, 2011). [Platform Presentation] 

Rush University
ROS/MAP Investigator Meeting in Chicago, Ill. (2011)

• Shulman JM. Genomics of cognitive decline and neuropathology. Presented at the Rush University, ROS/MAP Investigator Meeting in Chicago, Ill. (2011). [Oral Presentation] 

American Society of Human Genetics (ASHG)
60^th Annual Meeting in Washington, DC (Nov. 2-6, 2010)

• Shulman JM, Chipendo1 P, Aubin C, Kramer P, Schneider JA, Bennett DA, et al. Enhancing power for gene discovery in Alzheimer's disease: Intermediate phenotypes and functional validation in drosophila. Presented at the American Society of Human Genetics (ASHG), 60^th Annual Meeting in Washington, DC (Nov. 2-6, 2010). [Platform Presentation] 

American Academy of Neurology (AAN)
62^nd Annual Meeting in Toronto, Canada (April 10-17, 2010)

• De Jager P, Chibnik L, Aggarwal N, Shulman J, Schneider J, Evans D, et al. Relation of the Alzheimer's disease susceptibility allele at the CR1 locus to cognitive decline and Alzheimer's disease neuropathology in older persons. Neurology. 2010;74(9 Suppl 2):A97. [Platform Presentation] 
• Shulman JM, Aubin C, Tran D, Kramer P, Feany MB, Bennett D, et al. Enhancing power for gene discovery in Alzheimer's disease: Intermediate phenotypes and functional validation in drosophila. Neurology. 2010;74(9 Suppl 2):A500. [Platform Presentation] 
• Xia Z, Chibnik LB, Shulman JM, Aubin C, Tran D, Glanz BI, et al. Alzheimer's disease risk alleles in PCDH11X and SORL1 are associated with the rate of cognitive decline in subjects with multiple sclerosis. Neurology. 2010;74(9 Suppl 2):A313-4. [Platform Presentation] 

Rush University
CHAP Investigator Meeting in Chicago, Ill. (2010)

• Shulman JM. Genome-wide association scans for cognitive decline. Presented at the Rush University, CHAP Investigator Meeting in Chicago, Ill. (2010). [Oral Presentation] 

Genetics Society of America (GSA)
41^st Annual Drosophila Research Conference in Pittsburgh, Penn. (March 22-26, 2000)

• Shulman JM. A role for PAR-1 in oocyte determination. Presented at the Genetics Society of America (GSA), 41^st Annual Drosophila Research Conference in Pittsburgh, Penn. (March 22-26, 2000). [Platform Presentation] 

British Society for Developmental Biology (BSDB)
BSCB/BSDB Joint Spring Meeting in Manchester, England (April 13-16, 1999)

• Shulman JM. A drosophila homologue of c. elegans PAR-1. Presented at the British Society for Developmental Biology (BSDB), BSCB/BSDB Joint Spring Meeting in Manchester, England (April 13-16, 1999). [Platform Presentation] 

Genetics Society of America (GSA)
40^th Annual Drosophila Research Conference in Bellevue, Wash. (March 24-28, 1999)

• Shulman JM. A drosophila homologue of c. elegans PAR-1. Presented at the Genetics Society of America (GSA), 40^th Annual Drosophila Research Conference in Bellevue, Wash. (March 24-28, 1999). [Platform Presentation] 

Genetics Society of America (GSA)
39^th Annual Drosophila Research Conference in Washington, DC (March 25-29, 1998)

• Shulman JM. Subcellular relocalization of dishevelled mediates polarity signaling. Presented at the Genetics Society of America (GSA), 39^th Annual Drosophila Research Conference in Washington, DC (March 25-29, 1998). [Platform Presentation] 

Genetics Society of America (GSA)
37^th Annual Drosophila Research Conference in San Diego, Calif. (April 27 - May 1, 1996)

• Shulman JM. Dishevelled is a multifunctional signal transducer. Presented at the Genetics Society of America (GSA), 37^th Annual Drosophila Research Conference in San Diego, Calif. (April 27 - May 1, 1996). [Platform Presentation]